Shares in Britain's Pharmagene Plc (London:PGN.L - News) rallied on Wednesday after the drug discovery firm said it had signed a deal to provide drug testing techniques to U.S. pharmaceutical company Bristol-Myers Squibb (NYSE:BMY - News).